Zobrazeno 1 - 10
of 11
pro vyhledávání: '"T Alonso Dominguez"'
Autor:
J Plaza-Aniorte, M Soria-Soto, J Leon-Villar, I Gorostiza-Frias, JC Titos-Arcos, A Espuny-Miró, T Alonso-Dominguez, P Selvi-Sabater, MM Sanchez-Catalicio, N Manresa-Ramón
Publikováno v:
Other hospital pharmacy topics.
Background Lenalidomide is one of the main drugs for the treatment of multiple myeloma, which has a high cost per patient. Purpose To describe and analyse the use of lenalidomide in multiple myeloma. Material and methods This retrospective study cove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74d15b1c838f0f1704c902b63e34514f
https://doi.org/10.1136/ejhpharm-2017-000640.415
https://doi.org/10.1136/ejhpharm-2017-000640.415
Autor:
N Manrsesa-Ramon, J Leon-Villa, T Alonso-Dominguez, Mdm Sanchez-Catalcio, C Garcia-Motos, JC Titos-Arcos, I Gorostiza-Frias, P Selvi-Sabater, M Soria-Soto, J Plaza-Aniorte
Publikováno v:
Drug information and pharmacotherapy.
Background Health systems promote patient involvement in healthcare decisions. In order to achieve this, patients need information and often this is supplied as written material so that the readability of the text becomes a quality indicator. Purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b37e7d64dc033058906d5513495fc217
https://doi.org/10.1136/ejhpharm-2017-000640.307
https://doi.org/10.1136/ejhpharm-2017-000640.307
Autor:
A Aranda-Garcia, N Manresa-Ramón, A Espuny-Miró, M Soria-Soto, I Gorostiza-Frias, MM Sanchez-Catalicio, J Leon-Villar, JC Titos-Arcos, P Selvi-Sabater, T Alonso-Dominguez
Publikováno v:
Clinical pharmacy.
Background Orphan drugs mean a high economic impact and cost per patient, and in the past years there has been an increase in the number of patients. Purpose To describe and analyse the evolution of spending on orphan drugs based on diagnosis. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6d45d07184e11c1d3a5e2a003fd926a
https://doi.org/10.1136/ejhpharm-2017-000640.127
https://doi.org/10.1136/ejhpharm-2017-000640.127
Autor:
I Sanchez-Quiles, N Manresa-Ramón, AM Rizo-Cerdá, N Bejar-Riquelme, C Garcia-Motos, PL Sansano-Montoya, P Selvi-Sabater, M Soria-Soto, T Alonso-Dominguez, JC Titos-Arcos
Publikováno v:
European Journal of Hospital Pharmacy. 23:A40.2-A40
Background Including a pharmacist within the multidisciplinary teams has been a basic objective in many hospitals in recent years. Purpose To assess the efficiency of pharmaceutical care in the internal medicine service, based on an analysis of the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::408433b124f051bd2f02a580ecd1abe5
https://doi.org/10.1136/ejhpharm-2016-000875.92
https://doi.org/10.1136/ejhpharm-2016-000875.92
Autor:
I Sanchez-Quiles, P Selvi-Sabater, R Manresa-Ramón, I Gorostiza-Frias, R Guerrero-Bautista, JC Titos-Arcos, T Alonso-Dominguez, A Gomez-Gil, M Ventura-Lopez, C Garcia-Motos
Publikováno v:
European Journal of Hospital Pharmacy. 23:A47.1-A47
Background Pharmaceutical interventions are a key strategy to ensure proper drug prescription and the effectiveness and safety of any treatment. Purpose To study the pharmaceutical interventions made in hospitalised patients between 2010 and 2015. Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::800484c1891cefd817aba483c9a323fc
https://doi.org/10.1136/ejhpharm-2016-000875.107
https://doi.org/10.1136/ejhpharm-2016-000875.107
Autor:
J Leon-Villar, P Selvi-Sabater, N Manresa-Ramón, A. Mulet Alberola, N Bejar-Riquelme, T Alonso-Dominguez, A Campo-Soria, I Gorostiza-Frias, R Guerrero-Bautista, I Sánchez-Martinez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A173.2-A173
Background The ambulatory dispensation area is one of the most important sections of the hospital pharmacy. Treatment of several pathologies, such as oncology disease, hepatitis C virus, human immunodeficiency virus and more, are dispensed in this ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9f9c8164a9eef24eb74e39423188432
https://doi.org/10.1136/ejhpharm-2016-000875.392
https://doi.org/10.1136/ejhpharm-2016-000875.392
Autor:
MA Arias-Moya, N De Bejar Riquelme, T Alonso-Dominguez, C Baños Cuello, P Selvi-Sabater, M Soria-Soto, I Sánchez-Martinez, I Gorostiza-Frias, N Manresa-Ramón, AM Rizo-Cerdá
Publikováno v:
European Journal of Hospital Pharmacy. 22:A11.2-A12
Background Ribavirin is a drug used to treat hepatitis, but it is also used (off-label) for the treatment of respiratory syncytial virus (RSV) Purpose To evaluate the efficacy and safety of ribavirin when used for RSV treatment in haematological pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::444de8bb1b920789b6d575fcb0c5e190
https://doi.org/10.1136/ejhpharm-2015-000639.27
https://doi.org/10.1136/ejhpharm-2015-000639.27
Autor:
B Arribas-Díaz, I Sánchez-Martinez, M Soria-Soto, N Manresa-Ramón, AM Rizo-Cerdá, JC Titos-Arcos, I Gorostiza-Frias, MA Arias Moya, T Alonso-Dominguez, P Selvi
Publikováno v:
European Journal of Hospital Pharmacy. 22:A11.1-A11
Background Given the large number of new drugs for the treatment of hepatitis C virus (HCV) and the high economic cost, it is important to decide which treatment is best suited to each patient. Purpose To evaluate the efficacy of triple therapy with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e905ad7b8a79dec5ddb32fc50ee67856
https://doi.org/10.1136/ejhpharm-2015-000639.26
https://doi.org/10.1136/ejhpharm-2015-000639.26
Autor:
I Gorostiza-Frias, T Alonso-Dominguez, I Sánchez-Martinez, P Selvi-Sabater, N Manresa-Ramón, AM Rizo-Cerdá, MC Sanchez-Mulero, C Caballero-Requejo, M.D. Nájera-Pérez, B Arribas-Díaz
Publikováno v:
European Journal of Hospital Pharmacy. 22:A14.2-A14
Background Major bleeding complications with LMWH treatment have been reported both in clinical studies and during post-marketing surveillance. Monitoring of anti-factor Xa activity is recommended in special populations treated with low molecular wei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86536041e4f8068d179d6c076a9667db
https://doi.org/10.1136/ejhpharm-2015-000639.33
https://doi.org/10.1136/ejhpharm-2015-000639.33
Autor:
N Manresa Ramon, A. Boso Ribelles, T Alonso Dominguez, AM Rizo Cerdá, P Selvi Sabater, M Ventura López, B Arribas Díaz, I. Sánchez Martínez, A. Morego Soler, M.C. Sánchez Mulero
Publikováno v:
European Journal of Hospital Pharmacy. 21:A180.1-A180
Background Inappropriate prescribing is highly prevalent in older people and has become a global healthcare concern. Purpose To detect inappropriate prescriptions for patients hospitalised in the Internal Medicine Ward according to STOPP/START criter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dacd707e53cdc3e485ca2e7b9e846866
https://doi.org/10.1136/ejhpharm-2013-000436.441
https://doi.org/10.1136/ejhpharm-2013-000436.441